KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Share-based Compensation (2016 - 2026)

Pfizer has reported Share-based Compensation over the past 18 years, most recently at $272.0 million for Q1 2026.

  • Quarterly Share-based Compensation rose 60.0% to $272.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $901.0 million through Mar 2026, down 30.48% year-over-year, with the annual reading at $799.0 million for FY2025, 8.89% down from the prior year.
  • Share-based Compensation was $272.0 million for Q1 2026 at Pfizer, up from $225.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $700.0 million in Q3 2024 and troughed at $86.0 million in Q2 2022.
  • The 5-year median for Share-based Compensation is $203.0 million (2025), against an average of $240.2 million.
  • Year-over-year, Share-based Compensation soared 363.58% in 2024 and then tumbled 71.29% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $508.0 million in 2022, then plummeted by 76.18% to $121.0 million in 2023, then surged by 478.51% to $700.0 million in 2024, then tumbled by 67.86% to $225.0 million in 2025, then rose by 20.89% to $272.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Share-based Compensation are $272.0 million (Q1 2026), $225.0 million (Q4 2025), and $201.0 million (Q3 2025).